Skip to main content

References

Website
  1. NCCN. Non–Small Cell Lung Cancer Guidelines. 2017.
  2. Mack PC et al. Cancer 2020.
  3. Gettinger S, et al. J Clin Oncol. 2016.
  4. Peters S et al. J Clin Oncol. 2017.
  5. Gainor JF et al. Clin Cancer Res. 2016.
  6. Dudnik E et al. J Thorac Oncol. 2018.
  7. Guisier F et al. J Thorac Oncol. 2019.
  8. Gutierrez ME et al. JCO Precision Onc. 2019.
  9. Leighl NB et al. Clin Cancer Res. 2019.
  10. Analysis of AACR Genie v8
  11. Amgen, 2021.
  12. Geva S et al. J Thoracic Onc. 2018.
  13. Keytruda® [package insert].
  14. Dudnik et al. J Thoracic Onc. 2017.
  15. Aggarwal C et al. JAMA Oncol. 2019.
  16. Hagemann IA et al. Cancer. 2015.
  17. Kopetz et al. NEJM. 2020.
  18. LUMAKRAS™ Prescribing Information, Thousand Oaks, CA: Amgen; 2020.
Lung Reference Card
  1. Maemondo et al. 2010 NEJM
  2. Mitsudomi et al. 2010 Lancet Oncol
  3. Zhou et al. 2011 Lancet Oncol
  4. Rosell et al. 2012 Lancet Oncol
  5. Sequist et al 2013 JCO
  6. Wu et al. 2014 Lancet Oncol
  7. Soria et al. 2017 NEJM
  8. Mok et al. 2016 NEJM
  9. Wu YL et al. 2017 Lancet Oncol
  10. Sabari JK, Shu CA, Park K, et al. Amivantamab in post-platinum EGFR Exon 20 insertion mutant non–small cell lung cancer. Presented at: IASLC 2020 World Conference on Lung Cancer Singapore. January 28-31, 2021. Abstract OA04.04
  11. LUMAKRAS Prescribing Information
  12. Shaw et al. 2013 NEJM
  13. Soria et al. 2017 Lancet Oncol
  14. Peters et al. 2017 NEJM
  15. Solomon et al. 2018 Lancet Oncol
  16. Larkins et al. 2016 Clin Cancer Res
  17. Kim et al. 2017 JCO
  18. Shaw et al. 2014 NEJM
  19. Solomon et al. 2018 Lancet Oncol
  20. ROZLYTREK Prescribing Information
  21. Shaw et al. 2014 NEJM
  22. TABRECTA Prescribing Information
  23. Paik, et al. NEJM 2020
  24. RETEVMO Prescribing Information
  25. GAVRETO Prescribing Information
  26. Drilon et al. 2018 NEJM
  27. KEYTRUDA Prescribing Information
  28. Yoh K et al. 2017 Lancet Respir Med
  29. Mazieres et al. 2016 Ann Oncol
  30. Camidge et al. 2018 JCO
Colorectal Reference Card
  1. Dung et al. 2018 JCO
  2. OPDIVO + YERVOY Prescribing Information
  3. S. Kopetz, et al, 2019 N Engl J Med
  4. ROZLYTREK Prescribing Information
  5. Drilon et al. 2018 NEJM
  6. Meric-Bernstam et al. 2019 Lancet Oncol
  7. Geyer et al. 2006 NEJM